Intrinsic Value of S&P & Nasdaq Contact Us

Teleflex Incorporated TFX NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
48/100
2/7 Pass
SharesGrow Intrinsic Value
$142.15
+13.5%
Analyst Price Target
$133.25
+6.4%
SharesGrow 7-Criteria Score All 7 criteria scored · income-related highlighted on this page

Teleflex Incorporated (TFX) has shown declining revenue growth over the past 3 years, expanding from $2.8B to $2.0B (average -8.5%/yr). The company reported a net loss of $906M in its most recent fiscal year, with earnings trending at -494%/yr. The net profit margin is -45.4%, which is negative. the company was profitable in 3 out of the last 4 years tracked. The gross margin is 56.2% (high), with a +1.3pp trend over the period. With a $6B market cap and MOAT composite score of 70/100, the company has a strong competitive position.

Criteria proven by this page:

  • GROWTH (15/100, Fail) — revenue or earnings are not growing
  • PAST (75/100, Partial) — profitability has been inconsistent. Looking at the full 41-year history, the company was profitable in 39 of 41 years — an excellent long-term track record
  • INCOME (10/100, Fail) — the company is currently operating at a loss
  • MOAT (70/100, Pass) — strong gross margins and market scale prove a durable competitive advantage

Overall SharesGrow Score: 48/100 with 2/7 criteria passed.

48/100
SG Score
View full scorecard →
VALUE
78/100
Price-to-Earnings & upside
→ IV page
~
FUTURE
40/100
Analyst consensus
→ Forecast
~
PAST
75/100
3/4 yrs profit
EPS –$20.25
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
MOAT
70/100
Score: 70/100
GM 56.2% (+1.3pp)
Proven by this page
GROWTH
15/100
Rev -8.5%/yr
NI -494%/yr
Proven by this page
INCOME
10/100
Margin -45.4%
$2.0B
Proven by this page
Teleflex Incorporated Earnings and Revenue History
Analyst Forecast →
Revenue  Actual & Estimate
Earnings & Profit Margin  Actual & Estimate
Metric TTM FY2025 FY2024 FY2023 FY2022
Revenue $2.96B$1.99B$3.05B$2.97B$2.79B
Gross Profit $1.58B$1.12B$1.7B$1.65B$1.53B
Gross Margin 53.3%56.2%55.9%55.4%54.9%
Operating Income $287.52M$255.8M$151.01M$506.31M$499.73M
Net Income $-905.64M$-905.64M$69.68M$356.33M$363.14M
Net Margin -30.6%-45.4%2.3%12%13%
EPS (Diluted) $-20.55$-20.25$1.48$7.53$7.68
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message